Stocksigma LogoStocksigma Logo

Lord's Mark Industries Reports H1'27 Results and Strategic Expansion

Lord's Mark Industries released revised results for the half-year ended 30th Sep'26. Consolidated revenue reached ₹71,876.76 lakh with EBITDA of ₹13,151

Lord's Mark Industries Reports H1'27 Results and Strategic Expansion

Lords Mark Industries Ltd · Others (Uncategorized) · 15 Nov 2026, 4:28 am

Lord's Mark Industries Reports H1'27 Results and Strategic Expansion Lord's Mark Industries released revised results for the half-year ended 30th Sep'26. Consolidated revenue reached ₹71,876.76 lakh with EBITDA of ₹13,151 lakh (18.30% margin), PBT of ₹11,254.33 lakh, and PAT of ₹8,200.86 lakh (11.41% margin). Standalone H1 revenue stood at ₹65,530.62 lakh with PAT at ₹7,956.22 lakh. Key growth drivers include securing 26 additional medical device licenses, commencing AI dialysis machine production in Bangalore with global exports starting late Dec'26, expanding US/UK subsidiaries, advancing CAR-T therapy trials, and constructing a third IVD manufacturing facility operational before Mar'28.

Original exchange filing (PDF)

More announcements from Lords Mark Industries Ltd

All Lords Mark Industries Ltd announcements